<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT2017022132704N1</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2017-10-28</date_registration>
      <primary_sponsor>Cognitive Sciences and Technologies Council</primary_sponsor>
      <public_title>Efficacy of neurocognitive rehabilitation after CABG surgery in improving quality of life</public_title>
      <acronym>CABG; CCRT; RCR; QoL</acronym>
      <scientific_title>Efficacy of neurocognitive rehabilitation after coronary artery bypass graft surgery in improving quality of life: A randomized controlled trial</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2017-10-17</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>75</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/25408</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Single blinded, Placebo: Used, Assignment: Parallel, Purpose: Treatment, Randomization description: This is a randomized controlled trial with pre-, post- and follow-up assessments that is going to be conducted in CCRT, active control and control groups. 75 outpatients will be selected by convenience sampling among patients after CABG surgery. Randomization will be carried out by the patients enrollment date in Tehran Heart Center(first month= CCRT group, second month= active control group, third month= control group), Blinding description: The randomization of volunteer patients for participation in the study will be carried out by the patients enrollment date in Tehran Heart Center (first month= CCRT group, second month= active control group, third month= control group). 
clinical personnel are not aware of randomization according to enrollment date.
Scores of computerized training are going to be recorded online and after the accomplishment of intervention, the data will be received from related corporation.</study_design>
      <phase>N/A</phase>
      <hc_freetext>cognitive deficit.</hc_freetext>
      <i_freetext>Intervention 1: CCRT Group:This group of patients is going to receive CCRT plus RCR to activate different cognitive functions including attention, working memory and inhibition.The computerized cognitive training program applied in this study is Maghzineh®. This package has 24 exercise steps that the difficulty of exercises gradually increases according to the subject's performance. CCRT will be conducted individually in 24, 20-minute sessions within 8 weeks. Intervention 2: Active cotrol Group: This group patients is going to receive a sham version of CCRT plus RCR. The sham version involves the same training program without adaptivity and the difficulty level remains constant across the entire intervention. Sham version of CCRT will be conducted individually in 24, 20-minute sessions within 8 weeks. Intervention 3: Control Group:Patients in this group is going to receive RCR without any cognitive intervention for 2 months.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Yes - There is a plan to make this available</results_IPD_plan>
      <results_IPD_description>What will be shared:
all data can be shared after removing the possibility of knowing individuals including: 
1. demographic data; 2. data of cognitive performance and quality of life in pre-, post- and follow-up assessments.

When:
data will be available before publishing results

To whom:
no limitation

Conditions:
publishing any result based on this research data is not allowed

Where to obtain:
1. send request to s.ajtahed@gmail.com
2. search on OSF.io website

How to obtain:
data is accessible in the mentioned website.

Comments:
</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Simin Sadat Ajtahed</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>6 Cheshmeh Alley., 18 Sialk Alley., Amirkabir Ave</address>
        <city>kashan</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>8716900000</zip>
        <telephone>+98 31 5534 1046</telephone>
        <email>s.ajtahed@gmail.com</email>
        <affiliation>College of Farabi, University of Tehran</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Hamed Ekhtiari</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>4th Phase of Pardis, Edalat square, Cognitive Science Blvd</address>
        <city>Tehran</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>3718117469</zip>
        <telephone>+98 21 7629 1130</telephone>
        <email>H.ekhtiari@gmail.com</email>
        <affiliation>Tehran University of Medical Sciences</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Male or female outpatients.
Aged between 40 and 80.
Capable of perception of the research nature.
Able to give informed consent before any study is written.
Capable to speak in Persian with study personnel.
Able to read and write and work with computer.
Participation in concurrent standard routine rehabilitation during the trial.</inclusion_criteria>
      <agemin>40 years</agemin>
      <agemax>80 years</agemax>
      <gender>Both</gender>
      <exclusion_criteria>Dependency on alcohol or drugs.
Has any mental disorders that might interfere with the exact assessment or accuracy of treatment.
Has any clinical conditions that cause the usage of prescribed drugs that could have any effect on the Attention.</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code>R41.84</hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword>Other specified cognitive deficit</hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Rehabilitation</i_code>
      <i_code>Placebo</i_code>
      <i_code>N/A</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>CCRT Group:This group of patients is going to receive CCRT plus RCR to activate different cognitive functions including attention, working memory and inhibition.The computerized cognitive training program applied in this study is Maghzineh®. This package has 24 exercise steps that the difficulty of exercises gradually increases according to the subject's performance. CCRT will be conducted individually in 24, 20-minute sessions within 8 weeks.</i_keyword>
      <i_keyword>Active cotrol Group: This group patients is going to receive a sham version of CCRT plus RCR. The sham version involves the same training program without adaptivity and the difficulty level remains constant across the entire intervention. Sham version of CCRT will be conducted individually in 24, 20-minute sessions within 8 weeks.</i_keyword>
      <i_keyword>Control Group:Patients in this group is going to receive RCR without any cognitive intervention for 2 months.</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Selective attention. Timepoint: pre-intervention, post-intervention, 6-month follow-up. Method of measurement: Flanker test.</prim_outcome>
      <prim_outcome>Sustained attention. Timepoint: pre-intervention, post-intervention, 6-month follow-up. Method of measurement: Continuous Performance test.</prim_outcome>
      <prim_outcome>Divided attention. Timepoint: pre-intervention, post-intervention, 6-month follow-up. Method of measurement: Useful Field of View.</prim_outcome>
      <prim_outcome>Working memory. Timepoint: pre-intervention, post-intervention, 6-month follow-up. Method of measurement: Digit Span test (Forward and Backward ).</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome>Quality of life. Timepoint: pre-intervention, post-intervention, 6-month follow-up. Method of measurement: Quality of Life Short Form (SF-36) questionnaire.</sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Tehran Heart Center</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2017-10-16</approval_date>
        <contact_name>Ethics committee of Tehran University of Medical Sciences</contact_name>
        <contact_address>16 Azar Ave., Enqelab Square- Tehran Tehran Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
